[1]Patent:CN108084161,2018,A.Locationinpatent:Paragraph0018;0069-0071
[2]Patent:CN110467600,2019,A.Locationinpatent:Paragraph0031-0037;0072;0073;0076;0077
[3]Patent:CN105017223,2017,B.Locationinpatent:Paragraph0037-0038;0040;0041;0043;0045;0048
[4]Patent:CN106256824,2016,A.Locationinpatent:Paragraph0034
[5]Patent:US2006/228411,2006,A1.Locationinpatent:Page/Pagecolumn2
[6]Patent:CN105693695,2016,A.Locationinpatent:Paragraph0028
[1]OrganicProcessResearchandDevelopment,2006,vol.10,p.751-756
[1]OrganicProcessResearchandDevelopment,2006,vol.10,p.751-756
[1]OrganicProcessResearchandDevelopment,2006,vol.10,p.751-756
[1]OrganicProcessResearchandDevelopment,2006,vol.10,p.751-756
[2]Patent:CN113527262,2021,A
[3]Patent:CN113527262,2021,A
Title: Lepak AJ, et al. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model. Antimicrob Agents Chemother. 2016 Jul 22;60(8):4764-9.